Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • CEOs who motivate with 'fightin' words' shoot themselves in the foot

  • Knowledgeable consumers more likely to buy when given fewer options

  • Targeting the brain to treat obesity

  • Early warning sign for babies at risk of autism: Early joint attention predicts later autism symptoms

  • Creating sustainable STEM teacher programs

  • Klotho: neuroprotective against Alzheimer's disease

  • Cell therapy for multiple sclerosis patients: Closer than ever?

  • Computerized ADHD testing

  • Charter schools nationwide more cost-effective, produce greater ROI

  • 'Quack' child psychology practices identified by study

  •